Analysis of fetomaternal outcome of COVID-19 antenatal mothers-initial experience

Authors

  • Priyanka Bhadana Department of Obstetrics and Gynaecology. ABVIMS and RML Hospital, Delhi, India
  • Ashok Kumar Department of Obstetrics and Gynaecology. ABVIMS and RML Hospital, Delhi, India
  • Indu Chawla Department of Obstetrics and Gynaecology. ABVIMS and RML Hospital, Delhi, India
  • Bani Sarkar Department of Obstetrics and Gynaecology. ABVIMS and RML Hospital, Delhi, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20210332

Keywords:

COVID-19, Antenatal, Feto-maternal outcome

Abstract

COVID-19 is an infectious disease caused by newly discovered single stranded RNA virus of Coronaviridae family. A retrospective study conducted in ABVIMS and RML hospital, Delhi in antenatal patients with COVID-19 infection detected by RT-PCR in nasopharyngeal and oral swab. It was found that patients with mean age of 27.2 years and mean gestational age of 39 weeks, mostly asymptomatic. Three patients undergone c section for obstetrical indications, while rest delivered vaginally. COVID-19 in pregnancy in small group of cases had good feto-maternal outcome but warrants further study.

Author Biographies

Priyanka Bhadana, Department of Obstetrics and Gynaecology. ABVIMS and RML Hospital, Delhi, India

ASSISTANT PROFESSOR

DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY

Ashok Kumar, Department of Obstetrics and Gynaecology. ABVIMS and RML Hospital, Delhi, India

Director Professor-department of obstetrics and gynaecology,

Indu Chawla, Department of Obstetrics and Gynaecology. ABVIMS and RML Hospital, Delhi, India

Professor and Head of department-department of obstetrics and gynaecology

Bani Sarkar, Department of Obstetrics and Gynaecology. ABVIMS and RML Hospital, Delhi, India

Professor-department of obstetrics and gynaecology,

References

WHO Coronavirus Disease (COVID-19) Dashboard. Available from: https://covid19.who.int/. Accessed on 21 May 2020.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet Lond Engl. 2020;395(10223):497-506.

Li H, Zhou Y, Zhang M, et al. Updated Approaches against SARS-CoV-2. Antimicrobial Agents Chemo. 2020;64(6):483-20.

Cohen J. Vaccine designers take first shots at COVID-19. Sci. 2020;368(6486):14-6.

Qiancheng X, Jian S, Lingling P, Lei H, Xiaogan J, Weihua L et al. Coronavirus disease 2019 in pregnancy. Int J Infect Dis. 2020;95:376-83.

Zhang L, Jiang Y, Cheng BH, Zhou XC, Li J, Tian JH et al. Analysis of the Pregnancy Outcomes in Pregnant Women With COVID-19 in Hubei Province. Zhonghua Fu Chan Ke Za Zhi. 2020;55(3):166-71.

Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020;9(1):51-60.

Wang X, Zhou Z, Zhang J, Zhu F, Tang Y, Shen X. A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery. Clinical Infectious Diseases. 2020;71(15):844-6.

Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet Lond Engl. 2020;395(10226):809-15.

Schoeman D, Fielding BC. Coronavirus envelope protein: current knowledge. Virol J. 2019;16(1):69.

Liu W, Wang Q, Zhang Q, Chen L, Chen J, Zhang B et al. Coronavirus disease 2019 (COVID-19) during pregnancy: a case series. Preprints 2020;2020:020373.

Downloads

Published

2021-01-28

Issue

Section

Case Series